News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-06-07-2016
Volume11
Issue 6

FDA Releases Data Integrity Guidance

The agency published guidance on data integrity as it is relates to CGMP compliance.

On April 14, 2016, FDA published Data Integrity and Compliance with CGMP, which addresses the role of data integrity in CGMP for drug manufacturing, finished pharmaceuticals, and positron emission tomography drugs, as required by 21 Code of Federal Regulations (CFR) parts 210, 211, and 2012. The guidance has been issued in response to an increasing amount of data integrity violations found by the agency during CGMP inspections. According to FDA, data integrity CGMP violations have led to FDA warning letters, import alerts, and consent decrees. The new guidance answers data integrity questions in the hope of clarifying what FDA expects from manufacturers.

The guidance states that data should be reliable and accurate, and companies should implement effective strategies to manage data integrity risks. Along with clarifying the definition of data integrity terms, the guidance addresses the exclusion of CGMP data, workflow validation, data access, audits, electronic records, and personnel training. FDA also clarifies sampling and testing requirements and how to address data integrity problems.

Source: FDA

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More